HIGHLIGHTS
- who: Thomas Tayntonthomas.taynton1@nhs.net and collaborators from the Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Castle Road, Cottingham, Hull, JQ, UK have published the paper: PRO: Biomarker surveillance for invasive fungal infections without antifungal prophylaxis could safely reduce antifungal use in acute leukaemia, in the Journal: (JOURNAL)
SUMMARY
Received 4 April 2022; accepted 7 June 2022 Mould-active antifungal prophylaxis is frequently used to prevent invasive fungal infection in patients with acute leukaemia being treated with intensive chemotherapy. Invasive fungal infections are difficult to diagnose, and despite the use . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.